Results 81 to 90 of about 568,486 (233)

Novel rodent models for macular research [PDF]

, 2010
BACKGROUND: Many disabling human retinal disorders involve the central retina, particularly the macula. However, the commonly used rodent models in research, mouse and rat, do not possess a macula.
Gesine Huber, Muehlfriedel, Regine, Huber, G., Feng, Yuxi, Seeliger, M., Tanimoto, Naoyuki, Tanimoto Naoyuki, Severin Heynen, Hans-Peter Hammes, Christian Grimm, Feng, Y., Imsand Coni, Imsand, Coni, Muehlfriedel Regine, Susanne C. Beck, Huber, Gesine, Heynen, S., Grimm Christian, Regine Muehlfriedel, Huber Gesine, vom Hagen Franziska, Coni Imsand, Imsand, C., Seeliger Mathias W., Mühlfriedel, R., Peichl, Leo, Mathias W Seeliger, vom Hagen, F., Mühlfriedel, Regine, Tanimoto, N., Heynen Severin, Hammes, Hans-Peter, Seeliger, Mathias W, Beck Susanne C., Seeliger, Mathias W., Peichl Leo, Yuxi Feng, Peichl, L., Beck, Susanne C; https://orcid.org/, Grimm, C., Feng Yuxi, Mathias W. Seeliger, Leo Peichl, Franziska vom Hagen, Grimm, Christian, Grimm, Christian; https://orcid.org/, vom Hagen, Franziska, Beck, S., Beck, Susanne Christiane, Hammes Hans-Peter, Susanne C Beck, Naoyuki Tanimoto, Hammes, H., Heynen, Severin, Beck, Susanne C.   +54 more
core   +2 more sources

Treatment Outcomes of Primary Bevacizumab Injection versus Primary Aflibercept Injection in Diabetic Macular Edema

The Iraqi Journal of Medical Sciences
Background: Visual impairment in diabetic retinopathy (DR) due to diabetic macular edema (DME) is common and disabling for increasing diabetic population all over the world.
Hind A. Mahdi
doaj   +6 more sources

Features in dynamics of macular pigment status and central retinal sensitivity in vitreoretinal surgery for diabetic macular edema

Офтальмохирургия, 2018
Purpose. To identify the features of macular pigment and sensitivity of the central retina in case of vitreoretinal surgery for diabetic macular edema. Material and methods.
M. M. Bikbov, R. R. Fayzrakhmanov, R. M. Zainullin, M. R. Kalanov, A. F. Zaynetdinov   +4 more
doaj   +1 more source

Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab: A Post Hoc Analysis of the Protocol T Randomized Clinical Trial.

JAMA ophthalmology, 2019
Importance The determination of optical coherence tomography (OCT) central subfield thickness (CST) is an objective measure, and visual acuity (VA) is a subjective measure.
N. Bressler, Isoken Odia, M. Maguire, A. Glassman, L. Jampol, Mathew W. MacCumber, C. Shah, D. Rosberger, Jennifer K. Sun   +8 more
semanticscholar   +1 more source

Incidence of Clinical and Subclinical Cystoid Macular Edema in Diabetic and Non-Diabetic Patients After Cataract Surgery by Means of Optical Coherence Tomography

Delhi Journal of Ophthalmology, 2018
Purpose: To evaluate the incidence of clinical and subclinical cystoid macular edema in diabetic and non-diabetic patients after cataract surgery by means of Optical Coherence Tomography (OCT).
Aditi Chinmay Deshpande, Nitin Prabhudesai, Chinmay V. Deshpande   +2 more
doaj   +1 more source

Comparison of Intravitreal Bevacizumab Upload Followed by a Dexamethasone Implant versus Dexamethasone Implant Monotherapy for Retinal Vein Occlusion with Macular Edema [PDF]

, 2012
Purpose: To compare the efficacy and safety of three intravitreal bevacizumab upload injections followed by a dexamethasone implant versus dexamethasone implant monotherapy in eyes with macular edema due to retinal vein occlusion.
Haritoglou, Christos, Mayer, Wolfgang J., Wolf, Armin, Kook, Daniel, Ulbig, Michael, Reznicek, Lukas, Remy, Matthias, Kampik, Anselm   +7 more
core   +1 more source

Surgical Management for Diabetic Macular Edema

, 2022
The vitreous body is recognized as one of the causes of diabetic macular edema (DME) via several mechanisms. The observation that spontaneous posterior vitreous detachment could lead to reduction or resolution of DME suggested that the surgical induction
Veritti D., Sarao V., Tadayoni R., Lanzetta P., Danese C., Sarao, V., Danese, C., Veritti, D., Lanzetta, P., Ramin Tadayoni, Daniele Veritti, Paolo Lanzetta, Valentina Sarao, Carla Danese   +13 more
core   +1 more source

Clinical outcomes of ranibizumab treatment in diabetic eye disease [PDF]

, 2015
Background: The vascular endothelial growth factor (VEGF) inhibitor ranibizumab is emerging as an efficacious treatment for diabetic macular oedema. Large clinical trials have shown improvements in visual acuity and reduced central retinal thickness ...
Comyn, OJ
core  

Intravitreal injection of triamcinolone acetonide for diabetic macular edema: Principles and practice

Indian Journal of Ophthalmology, 2006
Diabetic retinopathy is fast emerging as a leading cause of newly diagnosed legal blindness amongst the working population. Macular edema, as it is commoner, accounts for more vision impairment than neovascular proliferation in diabetic patients.
Vedantham Vasumathy, Kim Ramasamy
doaj  

Determination of serum lipid profile in patients with diabetic macular edema that referred to Shahid Beheshti and Ayatollah Rouhani Hospitals, Babol during 2011-2012

Caspian Journal of Internal Medicine, 2015
Background: Diabetes is a common metabolic disorder leading to the development of many complications, among which diabetic retinopathy and macular edema are the most significant. These complications can contribute to blindness if not diagnosed or treated
Seyed Ahmad Rasoulinejad, Habib-ollah Iri   +1 more
doaj